Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how

Pharmacological characterization of the interaction between umeclidinium and vilanterol in human bronchi

(2017) Luigino Calzetta et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Impact of LABA/LAMA combination on exercise endurance and lung hyperinflation in COPD: A pair-wise and network meta-analysis

(2017) Luigino Calzetta et al.   RESPIRATORY MEDICINE

Optimizing drug delivery in COPD: The role of inhaler devices

(2017) Paola Rogliani et al.   RESPIRATORY MEDICINE

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

(2017) Jadwiga A Wedzicha et al.   International Journal of Chronic Obstructive Pulmonary Disease

A Systematic Review With Meta-Analysis of Dual Bronchodilation With LAMA/LABA for the Treatment of Stable COPD

(2016) Luigino Calzetta et al.   CHEST

Magnitude of umeclidinium/vilanterol lung function effect depends on monotherapy responses: Results from two randomised controlled trials

(2016) James F. Donohue et al.   RESPIRATORY MEDICINE

Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy

(2015) Luigino Calzetta et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The safety of anticholinergic bronchodilators for the treatment of chronic obstructive pulmonary disease

(2015) DP Tashkin   Expert Opinion On Drug Safety

Assessing the clinical value of fast onset and sustained duration of action of long-acting bronchodilators for COPD

(2015) Mario Cazzola et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside

(2015) Mario Cazzola et al.   RESPIRATORY MEDICINE

Translational Study Searching for Synergy between Glycopyrronium and Indacaterol

(2014) Mario Cazzola et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi

(2014) Mario Cazzola et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

β2-Agonist Therapy in Lung Disease

(2013) Mario Cazzola et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The short, the long and the “ultra-long”: Why duration of bronchodilator action matters in chronic obstructive pulmonary disease

(2010) Kai M. Beeh et al.   ADVANCES IN THERAPY